Culture

Perfect transmission through barrier using sound

image: The phononic crystals are made by artificially placing the acrylic posts in the special pattern.

Image: 
The University of Hong Kong

The perfect transmission of sound through a barrier is difficult to achieve, if not impossible based on our existing knowledge. This is also true with other energy forms such as light and heat.

A research team led by Professor Xiang Zhang, President of the University of Hong Kong (HKU) when he was a professor at the University of California, Berkeley, (UC Berkeley) has for the first time experimentally proved a century old quantum theory that relativistic particles can pass through a barrier with 100% transmission. The research findings have been published in the top academic journal Science.

Just as it would be difficult for us to jump over a thick high wall without enough energy accumulated. In contrast, it is predicted that a microscopic particle in the quantum world can pass through a barrier well beyond its energy regardless of the height or width of the barrier, as if it is "transparent".

As early as 1929, theoretical physicist Oscar Klein proposed that a relativistic particle can penetrate a potential barrier with 100% transmission upon normal incidence on the barrier. Scientists called this exotic and counterintuitive phenomenon the "Klein tunneling" theory. In the following 100 odd years, scientists tried various approaches to experimentally test Klein tunneling, but the attempts were unsuccessful and direct experimental evidence is still lacking.

Professor Zhang's team conducted the experiment in artificially designed phononic crystals with triangular lattice. The lattice's linear dispersion properties make it possible to mimic the relativistic Dirac quasiparticle by sound excitation, which led to the successful experimental observation of Klein tunneling.

"This is an exciting discovery. Quantum physicists have always tried to observe Klein tunneling in elementary particle experiments, but it is a very difficult task. We designed a phononic crystal similar to graphene that can excite the relativistic quasiparticles, but unlike natural material of graphene, the geometry of the man-made phononic crystal can be adjusted freely to precisely achieve the ideal conditions that made it possible to the first direct observation of Klein tunneling," said Professor Zhang.

The achievement not only represents a breakthrough in fundamental physics, but also presents a new platform for exploring emerging macroscale systems to be used in applications such as on-chip logic devices for sound manipulation, acoustic signal processing, and sound energy harvesting.

"In current acoustic communications, the transmission loss of acoustic energy on the interface is unavoidable. If the transmittance on the interface can be increased to nearly 100%, the efficiency of acoustic communications can be greatly improved, thus opening up cutting-edge applications. This is especially important when the surface or the interface play a role in hindering the accuracy acoustic detection such as underwater exploration. The experimental measurement is also conducive to the future development of studying quasiparticles with topological property in phononic crystals which might be difficult to perform in other systems," said Dr. Xue Jiang, a former member of Zhang's team and currently an Associate Researcher at the Department of Electronic Engineering at Fudan University.

Dr. Jiang pointed out that the research findings might also benefit the biomedical devices. It may help to improve the accuracy of ultrasound penetration through obstacles and reach designated targets such as tissues or organs, which could improve the ultrasound precision for better diagnosis and treatment.

On the basis of the current experiments, researchers can control the mass and dispersion of the quasiparticle by exciting the phononic crystals with different frequencies, thus achieving flexible experimental configuration and on/off control of Klein tunneling. This approach can be extended to other artificial structure for the study of optics and thermotics. It allows the unprecedent control of quasiparticle or wavefront, and contributes to the exploration on other complex quantum physical phenomena.

Credit: 
The University of Hong Kong

The ABCs of species evolution

image: The ABCA1 protein flips the cholesterol from the inner to the outer layer of the cell membrane. This strengthens the ability of the skin to protect the body from external stimuli. The researchers suggest this played an important role in the evolution of vertebrates.

Image: 
Mindy Takamiya/Kyoto University iCeMS

Almost four decades of research have led scientists at Japan's Institute for Integrated Cell-Material Sciences (iCeMS) to propose that a family of transporter proteins has played an important role in species evolution. One protein in particular, called ABCA1, was likely crucial for vertebrate evolution by helping regulate when signals involved in cell proliferation, differentiation and migration enter a cell. This process was necessary for vertebrates to develop into more complex organisms with sophisticated body structures.

The ATP-binding cassette proteins (ABC) are very similar across species, including in bacteria, plants and animals. There are different types of ABC proteins with different transportation roles, importing nutrients into cells, exporting toxic compounds outside them, and regulating lipid concentrations within cell membranes.

iCeMS cellular biochemist Kazumitsu Ueda has studied human ABC proteins for 35 years, ever since he and his colleagues identified the first eukaryote ABC protein gene.

"We believe ABC proteins must have played important roles in evolution," Ueda says. "By transporting lipids, they enabled plants and animals to thrive on land by protecting them from water loss and pathogen infection. They are also assumed to have accelerated vertebrate evolution by allowing cholesterol to function as an intra-membrane signalling molecule."

Organisms that existed early in Earth's history were probably formed of DNA and proteins surrounded by a leaky lipid membrane. As the organisms evolved, their membranes were fortified to protect them from the external environment. But this meant only organisms that evolved special ABC transporters capable of carrying nutrients across the membrane survived. The ABC proteins also played important roles in generating an outer membrane that protected cells from external stresses and in removing harmful substances from inside.

Recently, Ueda and his team studied the roles of ABCA1, gaining deeper insight into how it regulates cholesterol. Specifically, they found that ABCA1 exports cellular phospholipids and cholesterol outside the cell for generating high-density lipoproteins, popularly called good cholesterol.

They also found that ABCA1 constantly flops cholesterol from the cell membrane's inner leaflet to its outer leaflet, maintaining a lower concentration on the inner side. This flopping is temporarily suppressed when the cell is exposed to an external stimulus, like growth hormone. The resultant accumulation of cholesterol in the inner leaflet triggers the recruitment of proteins to the membrane and modulates the signal transduction. Ueda and his team suggest that ABCA1 allowed vertebrates to evolve complicated biological processes and sophisticated bodies.

"ABCA1 is very unique and its functions surprised us," says Ueda. "Cholesterol's role was thought to focus mainly on physically strengthening the cell membrane and reducing its permeability to ions. Our research suggests it played a more important role in vertebrates, accelerating their evolution."

Credit: 
Kyoto University

Study suggests great earthquakes as cause of Arctic warming

image: Aleutian Islands are an archipelago comprising dozens of islands with 40 active and 17 dormant volcanoes

Image: 
Shutterstock

A researcher from MIPT has proposed a new explanation for the Arctic's rapid warming. In his recent paper in Geosciences, he suggests that the warming could have been triggered by a series of great earthquakes.

Global warming is one of the pressing issues faced by civilization. It is widely believed to be caused by human activity, which increases the concentration of greenhouse gases in the atmosphere. However, this view does not explain why temperatures sometimes rise fairly abruptly.

In the Arctic, one of the factors driving climate warming is the release of methane from permafrost and metastable gas hydrates in the shelf zone. Since researchers began to monitor temperatures in the Arctic, the region has seen two periods of abrupt warming: first in the 1920s and '30s, and then beginning in 1980 and continuing to this day.

Leopold Lobkovsky, who authored the study reported in this story, is a member of the Russian Academy of Sciences and the head of the MIPT Laboratory for Geophysical Research of the Arctic and Continental Margins of the World Ocean. In his paper, the scientist hypothesized that the unexplained abrupt temperature changes could have been triggered by geodynamic factors. Specifically, he pointed to a series of great earthquakes in the Aleutian Arc, which is the closest seismically active area to the Arctic.

To test his hypothesis, Lobkovsky had to answer three questions. First, did the dates of the great earthquakes coincide with temperature jumps? Second, what is the mechanism that enables the lithospheric disturbances to propagate over more than 2,000 kilometers from the Aleutian Islands to the Arctic shelf region? Third, how do these disturbances intensify methane emissions?

The answer to the first question came from historical data analysis. It turned out that the Aleutian Arc was indeed the site of two series of great earthquakes in the 20th century (more details below the text). Each of them preceded an abrupt rise in temperature by about 15 to 20 years.

It took a model of lithospheric excitation dynamics to answer the second question. The model used by the researcher describes the propagation of so-called tectonic waves and predicts that they should travel at about 100 kilometers per year. This agrees with the delay between each of the great earthquake series and the subsequent temperature hike, as it took the disturbances 15 to 20 years to get transmitted over 2,000 kilometers.

To answer the third question, the researcher proposed the following explanation: The deformation waves arriving in the shelf zone cause minor additional stresses in the lithosphere, which are sufficient to disrupt the internal structure of the metastable gas hydrates and permafrost storing captured methane. This releases methane into the water of the shelf and atmosphere, leading to climate warming in the region due to the greenhouse effect.

"There is a clear correlation between the great earthquakes in the Aleutian Arc and the phases of climate warming. A mechanism exists for physically transmitting the stresses in the lithosphere at the appropriate velocities. And these added stresses are capable of destroying metastable gas hydrates and permafrost, releasing methane. Each of the three components in this scheme is logical and lends itself to mathematical and physical explanation. Importantly, it explains a known fact -- the abrupt rise in temperature anomalies in the Arctic -- which remained unaccounted for by the previous models," Lobkovsky commented.

According to the researcher, his model will benefit from discussion and will likely be improved, and there is much to be done in order to confirm or rule out the proposed mechanism.

Credit: 
Moscow Institute of Physics and Technology

TPU chemists convert plastic bottle waste into insecticide sorbent

Scientists of Tomsk Polytechnic University proposed a method to create a sorbent for imidacloprid insecticide removal from water. The sorbent belongs to metal-organic frameworks, a class of non-conventional materials. The TPU chemists grew such a framework right on polyethylene terephthalate (PET) used to produce regular plastic bottles. The method is quite simple and allows converting used materials into a useful product. The research findings are published in Applied Materials Today academic journal (IF: 8,352; Q1).

Metal-organic frameworks are substances with a three-dimensional structure, where clusters or metal ions are bridged by organic ligands. The result is a porous material with the properties of both metals and organic compounds.

"Due to their porous structure and a number of other properties, metal-organic frameworks have a high potential as sorbents. We are particularly interested in the problem of insecticide sorption, which are extensively used in modern agriculture and accumulated in soil and water.

We have proposed a new method to synthesize a metal-organic framework named UiO-66 with zirconium ions. The source material is what interests us first of all," Pavel Postnikov, the research supervisor and Associate Professor of TPU Research School of Chemistry and Applied Biomedical Sciences, says.

The researchers experimented with imidacloprid. This is one of the most widespread insecticides used in agriculture, including against Colorado potato beetles.

"Imidacloprid accumulates in natural water bodies penetrating from soil. According to Canadian researchers, imidacloprid was detected in waters around the world at concentrations ranging from 0.001 to 320 micrograms per litre. UiO-66 is usually derived at high temperatures and pressure using commercial terephthalic acid. However, we used PET consisting of ethylene glycol with terephthalic acid. This acid is a structural material for organic linkers in frameworks and plastic bottle material already contains it," Oleg Semyonov, one of the article authors and Junior Research Fellow at TPU Research School of Chemistry and Applied Biomedical Sciences, explains.

To create a framework, the chemists cut the plastic into small squares and partially destroyed them in an acidic solution. Then, zirconium salts were added to the solution.

"Terephthalic acid is partially released from PET forming small "anchors" on the surface of the plastic pieces while a part of the acid remains in the solution. Zirconium ions attach to the "anchors" and then, the process of self-assembly inherent to metal-organic frameworks occurs and further results in a framework formed on the plastic surface. This framework is sensitive to imidacloprid and due to its porosity and physicochemical properties, it attracts insecticide molecules removing them from water," the researcher says.

"During the experiments, we ran the insecticide solution through the sorbent. The effective water purification took 15 grams of sorbent per 1 liter, which is a very good indicator. Besides, the sorbent may be reused several times. We reached up to five cycles during our experiments. However, we expect that the sorbent will retain its properties much longer," the scientist says.

In the long run, in practice, this sorbent can be used in filtration systems, for instance, at agricultural enterprises.

"Our sorbent also has one more advantage. Usually, metal-organic frameworks are powder-like. They choke filters so that filtration systems should be designed considering this feature. The particles of our sorbent are larger and they do not choke a filter.

In addition, due to larger particles, the throughput of the sorbent is higher and liquids penetrate easier. According to our calculations, in this case water passage requires one hundred times less pressure as compared to powders. Ultimately, it is important for the technology development and use of this sorbent in a real technological process," Oleg Semyonov adds.

The scientists are currently conducting experiments using other metal-organic frameworks derived from PET.

Credit: 
Tomsk Polytechnic University

Similar factors cause health disparities in cancer, COVID-19

image: John Carethers, M.D.

Image: 
Michigan Medicine

ANN ARBOR, Michigan -- Income level, employment, housing location, medical insurance, education, tobacco and alcohol use, diet and obesity, access to medical care. These are some of the factors causing worse cancer outcomes in people who are Black.

The same factors are also causing worse outcomes from COVID-19 in this population.

"The similarities between COVID-19 issues and cancer disparities is uncanny," says John M. Carethers, M.D., John G. Searle Professor and Chair of Internal Medicine at Michigan Medicine.

"In cancer we are seeing in slow motion what has been observed rapidly with COVID - that the same conditions in our society put specific groups at risk for both. If we can fundamentally change socioeconomic inequality, we theoretically could reduce disparities in both diseases," says Carethers, who is a member of the University of Michigan Rogel Cancer Center.

Carethers collaborated with Lisa A. Newman, M.D., MPH, from Weill Cornell Medicine and Robert A. Winn, M.D., from Virginia Commonwealth University on a paper published in Clinical Cancer Research that outlines the similar disparities occurring in cancer and COVID-19 and recommends potential policy changes and strategies to help improve outcomes.

Racial disparities in cancer outcomes are well-documented, with lower five-year survival rates for Blacks than whites within most cancer types. With COVID-19, about 20% of cases in the U.S. have occurred in people who are Black, even though that population represents only 13% of the population. Similarly, Latinos comprise 32% of COVID-19 infections but are only 17% of the population.

On the surface these seem like very different diseases - cancer is often caused by genetic defects, COVID-19 is an infectious disease. But, the researchers point out, issues including socioeconomic disadvantages, education, lifestyle factors, other medical conditions and limited access to medical care are fueling risk for both cancer and COVID-19 - and contributing to worse outcomes.

"Eliminating these disparities should be a public health imperative," the authors write.

The major battles for health disparities are insurance coverage and use of preventive health services that could help eliminate co-morbidities such as obesity and diabetes, Carethers notes. The authors offer several suggestions that would impact both cancer and COVID-19 outcomes:

Ensure diversity in clinical trial participants.

Support public hospitals to meet the health care needs of those who are medically underserved.

Improve access to technology so all populations can access telehealth services.

"These strategies are feasible, but will take political will, and in some cases, funding. It relies on what people are willing to do to make it work," Carethers says. "We have much to do at all levels."

Credit: 
Michigan Medicine - University of Michigan

Cooperation with R&D organizations is significantly distinctive for advanced innovators

image: Cooperation network configurations (share of those who chose the corresponding model in the total number of innovation-active manufacturing enterprises, %).

Image: 
V.Vlasova et.al.

The innovation performance of firms depends on their ability to innovate in cooperation with external partners. In a study, HSE researchers found that most of innovation in Russian manufacturing happens in a sort of open processes, but extensive cooperation networks are barely detectable. The study was published in the December issue of Foresight and STI Governance.

Using data collected in 2015 and 2018 from a specialized survey measuring the innovation activity of manufacturing enterprises, researchers from the Institute for Statistical Studies and Economics of Knowledge (ISSEK) of HSE University for the first time confirmed the widespread, but not unambiguously proven, hypothesis that the openness of innovation strategy contributes to better innovation performance.

The survey included manufacturing enterprises located in at least 40 regions of Russia. In 2015, the sample included 1,206 enterprises, of which 805 were innovation-active, meaning that they had innovation activities during the past three years, regardless of whether the activity resulted in the implementation of an innovation. In 2018, 545 enterprises of high- and medium-tech manufacturing industries (422 of which were innovation-active) were surveyed.

'With Russian data we have shown that firms able to create innovation of high degree of novelty usually interact with a wide range of partners, and, most importantly, closely cooperate with R&D organizations and universities in innovation.' says Valeriya Vlasova, study co-author and Research Fellow of the Laboratory for Economics of Innovation at HSE University.

In the innovation development process, firms may cooperate with different types of partners: with value chain members (clients and suppliers), competitors, public authorities, consulting firms, and institutional R&D performing organizations (universities and research organisations). The published paper examines 9 types of different partners with which businesses can work in a wide variety of combinations.

To identify patterns in the configuration of cooperation networks, the researchers investigated three aspects of network interaction: the choice of partners, the role of spatial distance, and the duration of joint projects. The analysis made it possible to demonstrate a positive relationship between the openness of an innovation strategy and enterprises' innovation performance, in terms of innovation novelty and export capacity.

The results of the study indicate that in Russian manufacturing, almost all innovation-active enterprises cooperate with external counterparties in the process of innovation creation (98.5%), but only a few firms are integrated into extensive networks.

The most common cooperative strategy is vertical cooperation that is the involvement of clients and suppliers in the innovation process. The geography of cooperation rarely extends beyond the region's borders and is mostly of an irregular (short-term) nature. More than 40% of the surveyed enterprises follow this model.

Integration into international networks is weak (less than 5% of surveyed enterprises following this model). A small number of enterprises that engage in international cooperation tend to rely on long-term linkages with academia, which is a distinctive feature of the most innovative Russian companies.

'Despite the stereotypes about the unreadiness of Russian science to provide quality applied results, it is the active cooperation with universities and research organizations that turns out to be a characteristic feature of enterprises capable to create highly innovative products that are competitive in global markets,' says Vitaliy Roud, study co-author and Deputy Head of the HSE Laboratory for Economics of Innovation.

Innovation-active high-tech and medium high-tech enterprises that are engaged in industry-science cooperation are more often focused on the creation of new and significantly improved products or business processes; their strategic focuses also include searching for new client groups and expanding their product lines.

Credit: 
National Research University Higher School of Economics

Understanding nanoparticle entry mechanism into tumors

Announcing a new publication for BIO Integration journal. In this commentary the authors Phei Er Saw and Sangyong Jon from Sun Yat-Sen University, Guangzhou, China and the Korea Advanced Institute of Science and Technology, Daejeon, Korea, consider how the entry mechanism of nanoparticles into tumors determines the future direction of nanomedicine development.

Enhanced permeability and retention (EPR) allows nanoparticles to passively accumulate at tumor sites via gaps between endothelial cells (inter-endothelial gaps) in tumor-associated blood vessels that have abnormal structural integrity with pores ranging in size from submicron to micron. The authors review future directions of nanomedicine development, focusing on the mechanism of nanoparticle entry into tumors instead of clinical transformation itself. Designing better nanoparticles to achieve efficient clinical transformation can be informed by a deep understanding of the mechanism of nanoparticle entry or the mode of action.

Credit: 
Compuscript Ltd

New mammal reference genome helps ID genetic variants for human health

The rhesus macaque is the most widely studied nonhuman primate in biomedical research. A genome sequencing project for this species, led by researchers at Baylor College of Medicine, the University of Missouri and the University of Washington, has created a new framework for study of this important primate. Research published in the journal Science has established a new reference genome assembly and identified more than 85 million genetic variants in the rhesus macaque, the largest database of genetic variation for any one nonhuman primate species to date.

"This is a major step forward in the amount of information we have about genetic variation in the rhesus macaque," said Dr. Jeffrey Rogers, associate professor at the Human Genome Sequencing Center and Department of Molecular and Human Genetics at Baylor and one of the corresponding authors of the study. "We have actually identified thousands of new mutations in the population of research animals. Now colleagues all over the country who are investigating various aspects of health and disease using rhesus macaques can begin to make use of that information."

Dr. Wesley C. Warren at the University of Missouri and Dr. Evan Eichler at the University of Washington, both corresponding authors of the study, used a combination of several advanced technologies to substantially improve the rhesus macaque reference genome assembly first created in 2007. The new reference genome published today provides a more complete and accurate picture of the rhesus macaque DNA sequence. This improvement can support more sophisticated and more detailed analyses of fundamental questions in molecular genetics, cell biology and physiology.

"When we coupled this higher quality genome reference with a broader sequencing of expressed genes, our team discovered gene structures unique to macaque as well as specific repeat sequences undergoing deletions that suggest evolutionary competition to suppress these elements from expanding continues today," said Warren, professor at the University of Missouri's Bond Life Sciences Center.

Researchers at Baylor's Human Genome Sequencing Center sequenced the genomes of 853 rhesus macaque from research institutions around the country and compared them to the new reference genome. The genome analysis showed that rhesus macaque have more genetic variants per individual than humans. Among the millions of genetic variants identified, researchers found several damaging mutations in genes known to cause genetic disorders in humans, including autism, inherited blindness and several others.

"We can find naturally occurring models of genetic disorders by surveying the rhesus macaque population," Rogers said. "We will find animals that naturally carry interesting and useful genetic mutations that can help us understand genetic variation and susceptibility to disease in humans. Rhesus macaques are also widely studied by primatologists and evolutionary biologists, so this new reference genome will also provide new insight into the evolution of the nonhuman primate and human genomes."

Credit: 
Baylor College of Medicine

Scientists at Tel Aviv University develop new gene therapy for deafness

image: Professor Karen Avraham and Shahar Taiber of Tel Aviv University.

Image: 
Tel Aviv University

A new study from Tel Aviv University (TAU) presents an innovative treatment for deafness, based on the delivery of genetic material into the cells of the inner ear. The genetic material "replaces" the genetic defect and enables the cells to continue functioning normally.

The scientists were able to prevent the gradual deterioration of hearing in mice that had a genetic mutation for deafness. They maintain that this novel therapy could lead to a breakthrough in treating children born with various mutations that eventually cause deafness.

The study was led by Professor Karen Avraham of the Department of Human Molecular Genetics and Biochemistry at TAU's Sackler Faculty of Medicine and Sagol School of Neuroscience. The paper was published in EMBO Molecular Medicine on December 22, 2020.

Deafness is the most common sensory disability worldwide. According to the World Health Organization, there are about half a billion people with hearing loss around the world today, and this figure is expected to double in the coming decades. One in every 200 children is born with a hearing impairment, and one in every 1,000 is born deaf. In about half of these cases, deafness is caused by a genetic mutation. There are currently about 100 different genes associated with hereditary deafness.

"In this study we focused on genetic deafness caused by a mutation in the gene SYNE4 - a rare deafness discovered by our lab several years ago in two Israeli families, and since then identified in Turkey and the UK as well," Professor Avraham reports. "Children inheriting the defective gene from both parents are born with normal hearing, but they gradually lose their hearing during childhood. The mutation causes mislocalization of cell nuclei in the hair cells inside the cochlea of the inner ear, which serve as soundwave receptors and are essential for hearing. This defect leads to the degeneration and eventual death of hair cells."

"We implemented an innovative gene therapy technology: we created a harmless synthetic virus and used it to deliver genetic material - a normal version of the gene that is defective in both the mouse model and the affected human families," says Shahar Taiber, one of Professor Avraham's students on the combined MD-PhD track. "We injected the virus into the inner ear of the mice, so that it entered the hair cells and released its genetic payload. By so doing, we repaired the defect in the hair cells and enabled them to mature and function normally."

The treatment was administered soon after birth and the mice's hearing was then monitored using both physiological and behavioral tests. "The findings are most promising," says Professor Jeffrey Holt from Boston Children's Hospital and Harvard Medical School, a collaborator on the study. "Treated mice developed normal hearing, with sensitivity almost identical to that of healthy mice who do not have the mutation."

The scientists are now developing similar therapies for other mutations that cause deafness.

"This is an important study that shows that inner ear gene therapy can be effectively applied to a mouse model of SYNE4 deafness to rescue hearing," says Prof. Wade Chien, MD, from the NIDCD/NIH Inner Ear Gene Therapy Program and Johns Hopkins School of Medicine, who was not involved in the study. "The magnitude of hearing recovery is impressive. This study is a part of a growing body of literature showing that gene therapy can be successfully applied to mouse models of hereditary hearing loss, and it illustrates the enormous potential of gene therapy as a treatment for deafness."

Credit: 
American Friends of Tel Aviv University

With COVID exacerbating superbug threat, researchers ID new weapon

image: Corrie Detweiler in the lab at CU Boulder.

Image: 
CU Boulder

As scientists around the globe wage war against a novel, deadly virus, one University of Colorado Boulder lab is working on new weapons to battle a different microbial threat: a rising tide of antibiotic-resistant bacteria which, if left unchecked, could kill an estimated 10 million people annually by 2050.

"The COVID-19 situation is definitely putting us at risk for increasing resistance to antibiotics, so it's more important now than ever that we come up with alternative treatments," said Corrie Detweiler, a professor of molecular, cellular and developmental biology who has spent her career seeking those alternatives.

In a paper published Friday in the journal PLOS Pathogens, Detweiler and her research team unveil their latest discovery--a chemical compound that works with a host's innate immune response to push past cellular barriers that help bacteria resist antibiotics.

Along with their other recently published discoveries, the authors say, the finding could lead to a new arsenal for fighting what could be the next big public health threat.

"If we don't solve the problem of finding new antibiotics or somehow making old antibiotics work again, we are going to see sharply increasing deaths from bacterial infections we thought we had beaten decades ago," said Detweiler. "This study offers a totally new approach and could point the way toward new drugs that work better and have fewer side effects."

In the United States alone, 35,000 people die annually from bacterial infections that could not be treated because they've grown resistant to existing drugs. Countless others suffer life-threatening bouts with once-easily treatable illnesses like strep throat, urinary tract infections and pneumonia. By 2050, the authors note, there could be more deaths from antibiotic resistance than from cancer.

"As our existing antibiotics adapt and work less, we risk essentially going back to a period 100 years ago, when even a minor infection could mean death," said Detweiler.

The pandemic has shone even more light on the problem, she notes, as many patients die not from the virus itself but from hard-to-treat secondary bacterial infections.

Meanwhile, she and other scholars worry that heightened use of antibiotics to prevent or treat those secondary infections, while at times necessary, may be exacerbating resistance.

Most antibiotics in use today were developed in the 1950s, and pharmaceutical companies have since scaled back on research in the field in favor of more profitable ventures.

To feed the pipeline, Detweiler's lab developed a technique called SAFIRE for screening for new small molecules which work differently than older drugs.

Of 14,400 candidates screened from a library of existing chemicals, SAFIRE identified 70 that hold promise.

The new paper centers around "JD1," which appears to be particularly effective at infiltrating what are known as "Gram-negative bacteria."

With a tough exterior membrane that prevents antibiotics from accessing the cell, and another interior membrane providing a buffer, these bacteria (including Salmonella and E. coli) are inherently difficult to treat.

But unlike other drugs, JD1 takes advantage of the host's initial immune assault on that outer bacterial membrane, then slips inside and goes after the inner membrane too.

"This is the first study to show that you can target a Gram-negative bacteria's inner membrane by exploiting the innate immune response of the host," Detweiler said.

In laboratory and rodent experiments, JD1 reduced survival and spread of Gram-negative bacteria called Salmonella enterica by 95%.

But while it damaged the bacterial cell membranes, it couldn't penetrate the fine layer of cholesterol that lined its mammalian host's cell membranes.

"Bacteria are vulnerable to JD1 in a way that our cells are not," said Detweiler, noting that for this reason, side-effects would likely be minimal.

Further studies are underway to explore JD1 and other compounds like it.

Meanwhile, Detweiler has formed a spin-off company to help commercialize other compounds which work by inhibiting pumps, called "efflux pumps," that bacteria use to pump out antibiotics.

"The reality is, evolution is way smarter than all of the scientists put together and these bacteria will continue to evolve to resist what we throw at them," she said. "We cannot rest on our laurels. We have to keep feeding the pipeline."

Credit: 
University of Colorado at Boulder

Scientists identify new gene involved in autism spectrum disorder

image: Bruce Beutler, M.D.

Image: 
Photo taken by Brian Coats for UT Southwestern Medical Center

DALLAS - Dec. 22, 2020 - UT Southwestern scientists have adapted a classic research technique called forward genetics to identify new genes involved in autism spectrum disorder (ASD). In a study published this week in eLife, the researchers used this approach in mice to find one such gene called KDM5A.

Approximately 1 in 54 children in the U.S. is diagnosed with ASD, a neurodevelopmental disorder that causes disrupted communication, difficulties with social skills, and repetitive behaviors. As a disease with a strong genetic component, it is hypothesized that thousands of genetic mutations may contribute to ASD. But to date, only about 30 percent of cases can be explained by known genetic mutations.

For decades, forward genetics has been used to find mutations that cause disease. It involves inducing genetic mutations in mice, screening for certain phenotypes, and then identifying the causative mutation through sequencing of all genetic material of an organism, or its genome.

"The difficult part in the beginning was finding the mutations. It had to be done by laborious cloning," says Nobel Laureate Bruce Beutler, M.D., director of the Center for the Genetics of Host Defense at UTSW and study co-author. "We developed a platform wherein when you see a phenotype you know the mutational cause at the same time." So, when a mouse displays a certain phenotype or trait of interest, the researchers would know almost instantly what genetic mutation was causing it. This technique, combined with a screen developed to ascertain ASD-like behaviors in mice, made it possible to use forward genetics for the first time to identify new genetic mutations in ASD.

Beutler won the 2011 Nobel Prize in Physiology or Medicine for his discovery of a family of receptors that allow mammals to sense infections when they occur, triggering a powerful inflammatory response.

In this study, the research team documented the quality and number of vocalizations in young mice carrying induced genetic mutations. Given that one of the common characteristics seen in autism is disrupted communication, the researchers were on the lookout for mice that had changes in these vocalizations.

"Initially we found that the quality of these vocalizations was different in mice with KDM5A mutations. Looking more closely, we found that mice completely lacking KDM5A have a severe deficit in the number of these vocalizations," says Maria Chahrour, Ph.D., who led the study. Chahrour is assistant professor of neuroscience, psychiatry, and in both the Eugene McDermott Center for Human Growth and Development and Center for the Genetics of Host Defense.

In addition to loss of vocalizations, mice lacking KDM5A also displayed repetitive behaviors and deficits in social interaction, learning, and memory - all hallmarks of ASD.

Because this was the first time that KDM5A had been implicated in ASD, the researchers looked into whether KDM5A mutations could be found in patients with autism as well. Through international collaborative efforts, the group was able to identify nine patients with ASD and causative KDM5A mutations. Strikingly, eight out of nine patients also had a complete lack of speech.

Though one broad term is used for ASD, Chahrour likens autism to cancer in that it is a collection of individually rare forms of autism with hundreds of different genetic causes. Mutations in KDM5A appear to be one of those forms.

"We've identified a new genetic subtype of autism, and we're going to look for more patients with mutations in KDM5A," explains Chahrour. "This has a direct impact on diagnosis too. When a clinician gets a clinical sequencing result that reports a KDM5A mutation, it's now a known autism gene."

Aside from the impact on diagnosis, the researchers are interested in further characterizing this gene's role in the brain. With a better understanding of what KDM5A is doing in the brain, scientists might be able to find a target to aid in future studies investigating possible treatments.

This work will expand beyond KDM5A as researchers search for more genes involved in ASD, a subject of research for which the simplicity and efficiency of forward genetics comes in handy.

"The wonderful thing about forward genetics is that we can grind away at the genome. We know progressively how much of the genome we've saturated," says Beutler, who estimates that his group has already mutated about half of the mouse genome with this approach.

Chahrour, also a member of UT Southwestern's Peter O'Donnell Jr. Brain Institute, looks forward to continuing to screen these animals for ASD genes, adding, "At some point we'll get to a stage where we can saturate the genome with mutations and theoretically find every gene that functions in social behavior and cognition. That's the ultimate goal."

Credit: 
UT Southwestern Medical Center

Tracing the many paths of vision

image: The catalog allowed studying individual cell types in the retina and linking them to a specific structure, function and behavioral response.

Image: 
MPI of Neurobiology / Koelsch

Retinal ganglion cells (RGCs) are the bottleneck through which all visual impressions flow from the retina to the brain. A team from the Max Planck Institute of Neurobiology, University of California Berkeley and Harvard University created a molecular catalog that describes the different types of these neurons. In this way, individual RGC types could be systematically studied and linked to a specific connection, function and behavioral response.

When zebrafish see light, they often swim towards it. Same with prey, although the signals are entirely different. A predator, on the other hand, prompts the fish to escape. That's good, because a mix-up would have fatal consequences. But how does the brain manage to react to a visual stimulus with the proper behavior?

Optical signals are generated by photons that bombard the retina of the eye. Neurons in the retina collect and process these impressions. While doing so, the retina focuses on the important details: Is there contrast or color? Are there small or large objects? Is something moving? Once these details are filtered out, retinal ganglion cells (RGCs) send them to the brain, where they are translated into a specific behavior.

As the only connection between the retina and the brain, RGCs play a central role in the visual system. We already knew that specific RGC types sends different details to different regions of the brain. However, it has been unclear how RGC types differ on the molecular level, what their respective functions are, and how they help to regulate context-dependent behavior.

To begin to solve this puzzle, a team led by Yvonne Kölsch from Herwig Baier's laboratory analyzed the genetic diversity of RGCs. Collaborating with the groups of Joshua Sanes (Harvard University) and Karthik Shekhar (UC Berkeley), they determined the transcriptomes, i. e., the patterns of all active genes, in RGCs and thereby assigned each cell its own unique molecular fingerprint. A computational analysis of the large scale dataset comprising >30,000 RGCs identified at least 32 different RGC types based on similarities.

Cell type specific genes

In this new catalog of neuronal cell types, the scientists found genes that are only active in certain RGC types. With the help of these genes and targeted genome editing, they gained genetic access to selected RGC types - the prerequisite for studying their structure and function.

In the almost transparent zebrafish, it was thus possible to fluorescently label RGC types and to record in which brain regions their axonal projections end. It was also possible to determine which visual detail a RGC type prefers. To do this, the researchers showed fish larvae various visual stimuli and investigated which of them activate a particular cell type. For example, one RGC type reacted to light, but not to the simulation of an attacking predator.

What does it mean for the fish's behavior if this cell type no longer functions? Normally, fish larvae prefer a bright environment in which they can perceive their surroundings and easily find food. When the scientists inactivated the above cell type measuring light conditions, the fish lost their ability to navigate to their favorable environment - a clear sign that the RGC type is especially important for approaching light.

Highly specialized genes

The analysis links a molecularly described RGC type to a specific structure, function and behavioral response. It also shows how specialized individual RGC types are - from the brain regions they contact to their role in behavior. This finding supports the theory that highly specialized neuronal circuits are the brain's secret to translating diverse visual stimuli into proper behavior.

In the future, the molecular catalog will allow to systematically investigate other RGC types. The study thus takes us a decisive step forward in gaining a comprehensive understanding of the functional architecture of the visual system.

Credit: 
Max-Planck-Gesellschaft

Changing the perspective on the 'Cinderella of the cytoskeleton'

SETD2 is a protein well known as a chromatin remodeler, one that helps turn genes on or off by modifying histone proteins in the nucleus of the cell. When researchers discovered that SETD2 is mutated or lost in several cancer types, most commonly a type of kidney cancer called clear-cell renal cell carcinoma, all eyes turned toward SETD2 function in the nucleus of the cell to explain these cancers.

In 2016, the lab of Dr. Cheryl Walker, director of the Center for Precision Environmental Health at Baylor College of Medicine, made the unexpected discovery that SETD2 not only remodels chromosomes in the nucleus, but also microtubules of the cytoskeleton outside the nucleus. The cytoskeleton is a dynamic network of interlinking protein thread-like structures, including filaments and microtubules that extend throughout the cell. It gives a cell its shape and internal organization and provides mechanical support that enables cells to carry out essential functions like division and movement.

The Walker team found that SETD2 tags cytoskeleton microtubules with a methyl group. Loss of SETD2 resulted in defective delivery of chromosomes and problems with the separation of daughter cells during cell division.

"Our findings suggested that defects in SETD2 could not only affect gene expression but also functions controlled by the cytoskeleton, such as movement, metastasis and migration, which are very important for cancer cells," Walker said. "We wondered whether SETD2 might target other cytoskeletal proteins."

SETD2 works with Huntingtin and actin to regulate cell migration

Actin proteins, which form the filaments of the cytoskeleton, stood out as a prime target for SETD2. Two recent papers from the Walker lab have now revealed the role of SETD2 in modifying the actin cytoskeleton and its implications for two important functions of cancer cells, cell migration and autophagy.

One of the first findings was that SETD2 interacts with the actin cytoskeleton and is able to modify actin in cells or in reactions using purified proteins. SETD2 adds three methyl groups to actin at a location called lysine-68. Interestingly, they found that SETD2 interacted with two other proteins to methylate actin in cells: Huntingtin (HTT) and the actin-binding adapter HIP1R.

Trimethylated lysine-68 regulates the normal dynamics of actin, including polymerization and depolymerization. Disrupting the SETD2-HTT-HIP1R association inhibited actin methylation, caused defects in actin dynamics and impaired cell migration, an important function of cancer cells.

"These findings were very exciting because, to our knowledge, nobody had investigated the significance of the SETD2-Huntingtin interaction that had been known for over two decades," said first and co-corresponding author Riyad Navroz Seervai, an M.D./Ph.D. student in the Medical Scientist Training Program who completed his Ph.D. thesis in the Walker lab. "There was a limited list of papers about Huntingtin involvement in actin dynamics and cell migration, but enough to pursue the SETD2-Huntingtin-actin connection."

Together, these data provided a new understanding of how defects in SETD2 and HTT can drive disease via disrupting cytoskeletal methylation and defects in cell migration. The researchers also were able to manipulate the SETD2-HTT-actin axis to show that changes in cell migration are specific to this new target of SETD2 (actin) rather than to chromatin or microtubules.

Read all about this work in the journal Science Advances.

A role for SETD2 in autophagy

The group also explored the influence of SETD2 on autophagy, a mechanism cells use to remove unnecessary or dysfunctional components.

"Dr. Walker's lab has an extensive background and expertise in studying autophagy," Seervai said. "There was always a suspicion that SETD2 might be involved in this process, but it had not been tested. This project got off the ground once we performed the initial experiments looking at autophagy markers and found differences between cells with functional SETD2 and those without it."

As they had found when studying cell migration, disrupting SETD2's ability to methylate actin at lysine-68 caused defects in actin polymerization. In autophagy, disrupted actin polymerization altered actin's interaction with another protein called WHAMM. As a result, the cells had autophagy defects. Significantly, there were no changes in the expression of any autophagy-related genes, further suggesting a role for SETD2 cytoskeleton modification rather than its chromatin function.

Find all the details of this work in the journal Biochemical and Biophysical Research Communications.

A rapidly growing field of cell biology

"Actin modifications, such as the addition of methyl groups described here, have been aptly dubbed the 'Cinderella of the cytoskeleton' and are only now being recognized as key regulators of cytoskeleton dynamics," Seervai said. "But our findings and those of other groups are changing this perspective. More researchers are expressing interest in this new aspect of cytoskeleton regulation and we anticipate new discoveries pointing at potential new therapies for conditions involving cytoskeleton defects."

Seervai was also involved in organizing a special interest subgroup at the ASCB/EMBO Cell Bio 2020 virtual meeting on post-translational modifications of the cytoskeleton, including actin and tubulin. "We had nearly 300 people, including the ASCB president, at our session this year. From what I've heard, this is a sign that things have turned a corner for the field since such a session was first organized several years ago."

Credit: 
Baylor College of Medicine

Cost-effective hood reduces aerosol exposures to patients, otolaryngologists

(Boston)--The COVID-19 pandemic has continued to cause dramatic shifts in the practice of otolaryngology. Even with standard precautions such as physical distancing and wearing personal protective equipment, aerosol-generating procedures such as nasolaryngoscopy (a commonly performed in-office procedure in which a soft, flexible fiber-scope is passed through the nose and into the throat) and intranasal instrumentation were determined to carry a risk of potential transmission if not adequately protected.

In an effort to mitigate exposure to these airborne particles, researchers from Boston University School of Medicine (BUSM) designed and tested a prototype nasolaryngoscopy hood, worn by the patient that offers safe and effective protection in reducing aerosols exposures.

In order to test the efficacy of the hood, a particle counter was used to calculate the average number of 0.3-mm particles/L detected during various clinical scenarios that included sneezing, nasolaryngoscopy, sneezing during nasolaryngoscopy and topical lidocaine spray administration. Experiments were repeated to compare the effectiveness of the hood versus no protection.

When no patient barrier (hood or mask) was used, a significant increase in aerosols was detected during sneezing, sneezing during nasolaryngoscopy and topical spray administration. With the hood was in place, the level of aerosols returned to baseline levels in each scenario.

"This simple intervention allows patients to undergo routine flexible nasal laryngoscopy, even with topical lidocaine spray administration, with less risk to the provider," explained corresponding author Christopher Brook, MD, assistant professor of otolaryngology--head and neck surgery at BUSM. "If a patient begins to sneeze during the examination, our data suggest that providers will remain protected through the use of the hood," he added.

While this study evaluated the efficacy of the hood in the setting of a routine nasolaryngoscopy in reducing aerosol spread, there are other possible applications but also one major barrier to overcome. "For clinical use, either the hood would need to be mass produced to allow for single use, or a safe and effective protocol of cleaning and reusing each hood would need to be established," said Brook who also is an otolaryngologist at Boston Medical Center.

Credit: 
Boston University School of Medicine

No. 1 news release on EurekAlert!'s 2020 Trending List smashes previous all-time record for visits

image: The sixth most popular release in 2020 is also the first from China and described a newly unearthed prehistoric mammal whose ear bones helped scientists understand how they evolved.

Image: 
IVPP

The most-visited news release on EurekAlert! in 2020 racked up just under 1 million hits - the most in the site's near 25-year history.

The University of California, Riverside release is one of three about brain health on the 2020 Trending list in a year when COVID-19 dominated headlines across the globe. It described a mouse study that showed soybean oil induced negative changes to genes affecting neurological conditions like autism and Alzheimer's disease. The news release registered an unprecedented 987,050 visits, surpassing the previous record set in 2017 for yearly total views of a single release by almost 10%.

EurekAlert! is an editorially independent, nonprofit news release distribution platform operated by the American Association for the Advancement of Science (AAAS) as a free resource to journalists and the public. News releases hosted on EurekAlert! are produced and submitted by research institutions and journal publishers and must meet eligibility guidelines for acceptance.

In the fourth most-visited release, Swiss and Italian scientists proved a link between low gut microbial diversity and Alzheimer's disease. Researchers from Tokyo Metropolitan University found a new enzyme mutation that impacts how proteins cluster in the brain and cause Alzheimer's disease in the ninth most popular release.

Three COVID-19-related news releases appear on the list, starting with the second trending release. It described a research review that pointed to a relationship between cardio exercise and protection against COVID-19 respiratory symptoms. Potential coronavirus mitigation strategies also featured in the third and seventh news releases, in the form of an anti-parasitic drug and vitamin supplements, respectively. Overall, approximately 13% of news releases accepted by EurekAlert! in 2020 were COVID-related.

Half of the 2020 Trending releases originated outside the United States and, for the first time, a news release from China, by the Chinese Academy of Sciences, made the top 10. It describes the bones of a small prehistoric rodent, unearthed in northeast China, that clarified the evolution of mammalian ear bone structure. Another paleontology release detailed a specimen of the carnivorous Allosaurus, discovered in Utah, that became the oldest known of its species in North America.

Loading video...

jwplayer('player0').setup({
file: '//media.eurekalert.org/multimedia_prod/pub/media/252111_web.mp4',
image: '//media.eurekalert.org/multimedia_prod/pub/web/252111_web.jpg',
stretching: 'uniform',
autostart: 'false',
width: '100%',
aspectratio: '16:9',
fallback: 'true',
abouttext: 'EurekAlert! Multimedia',
aboutlink: 'https://www.eurekalert.org/multimedia'
});

VIDEO: The fifth most-visited release in 2020 included a video showing a wolf pup playing fetch with a handler. The study showed this behavior in wolf pups who had not had previous exposure to it.

Credit: Christina Hansen Wheat

Credit: 
EurekAlert!